<!DOCTYPE HTML>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<link rel="stylesheet" href="../styles.css"/>
<script src="https://ajax.googleapis.com/ajax/libs/jquery/3.4.1/jquery.min.js"></script>
<script src="functions.txt">
</script>
<!--
  INSERT TABLE TITLE BETWEEN THE TITLE TAGS
  -->
<title>Table&nbsp;17.16</title>
</head>
<body>
<!--
  INSERT TABLE BODY HERE
  -->
<table>
  <caption>
  Table&nbsp;17.16     Interpretation of the ratio of ZnPP:heme in the diagnosis of iron
disorders. From Labb&eacute; et.al., Clinical Chemistry
45: 146&ndash;148, 1999, with permission of the AACC.
  </caption>
  <thead class="reporttablehead">
    <tr>
      <th>Lab results</th>
      <th>Interpretation</th>
      <th>Recommendations</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Low ZnPP : heme <br/>(&lt; 60 µmol/mol)</td>
      <td class="left-aligned">Adequate systemic iron <br/>supply; no further <br/>deficiency work-up <br/>needed</td>
      <td class="left-aligned">Iron stores can be determined using serum<br/> ferritin concentration. If ZnPP : heme is<br/>
      &lt; 40 µmol/mol, consider testing for iron<br/> overload using either serum ferritin concen-<br/>
      tration or percentage transferrin saturation.</td>
    </tr>
    <tr>
      <td>Medium ZnPP : heme<br/> (60&ndash;80 µmol/mol)</td>
      <td class="left-aligned">Possible nonreplete iron <br/>status; consider inadequate<br/> diet, blood loss, anemia <br/>of chronic disease, and <br/> other causes</td>
      <td class="left-aligned">Hemoglobin or hematocrit values may indi-<br/>cate a state of iron depletion. If clinically<br/>indicated, measure serum ferritin to differ-<br/>entiate between low iron stores and block<br/> of iron release arising from inflammation.<br/>Identify the inflammation using C-reactive<br/>protein.</td>
    </tr>
    <tr>
      <td>High ZnPP : heme<br/>(&gt; 80 µmol/mol)<br/> and low ferritin<br/> (&lt; 20 µg/L)</td>
      <td class="left-aligned">Indication of iron-deficient<br/> erythropoiesis attributable<br/> to low marrow iron<br/> supply, possibly related to<br/> depleted iron stores</td>
      <td class="left-aligned">Iron supplementation indicated once abnor-<br/>mal blood loss, anemia of chronic disease,<br/> or chronic
       lead exposure has been ruled<br/>out. Monitor therapy with decrease in<br/>ZnPP : heme or 
       increase in reticulocyte count.</td>
    </tr>
    <tr>
      <td>High ZnPP : heme<br/>(&gt;80 µmol/mol)<br/> and high ferritin <br/>(&gt;200 µg/L)</td>
      <td class="left-aligned">Severe inflammatory block,<br/> anemia of chronic disease,<br/> other causes of impaired<br/>iron utilization.</td>
      <td class="left-aligned">Treat causes of impaired iron utilization.<br/>Effectiveness of iron supplementation is lim-<br/> ited. Consider severe chronic lead poisoning</td>
    </tr>
  </tbody>
</table>
</body>
</html>

